Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Orai1 is a plasma membrane protein that forms the pore of highly Ca2+-selective store-operated calcium entry (SOCE) channels, activated when the endoplasmic reticulum Ca2+ sensor STIM1 oligomerizes and binds to Orai1 upon ER store depletion. This interaction occurs at ER-plasma membrane junctions, where STIM1's CRAC activation domain (CAD) or SOAR engages Orai1's cytosolic C-terminal and N-terminal regions, triggering a cooperative wave of conformational changes across Orai1's four transmembrane domains to open the central pore lined by TM1. Orai1 channels exhibit extreme Ca2+ selectivity and mediate essential calcium influx for cellular processes like gene transcription, exocytosis, immune responses, and T-cell activation. STIM1, a single-pass ER membrane protein with luminal EF-hand and SAM domains, detects store depletion and links it to Orai1 gating. Dysfunctions, including loss-of-function mutations in Orai1 causing severe combined immunodeficiency (SCID) and gain-of-function mutations linked to tubular aggregate myopathy and Stormorken syndrome, underscore their roles in immunity and muscle function. Therapeutically, modulating Orai1/STIM1 is explored for immune disorders and inflammation, though challenges arise from the channel's allosteric gating and disease-associated mutations.
Allosteric activation by STIM1 binding to Orai1 C-terminus and N-terminus, inducing conformational changes in transmembrane domains to open the Ca2+ pore
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Orai1 (ORAI calcium release-activated calcium modulator 1); STIM1 (stromal interaction molecule 1) (Orai1; STIM1).